Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Case Rep ; 18(1): 84, 2024 Mar 03.
Article in English | MEDLINE | ID: mdl-38431685

ABSTRACT

BACKGROUND AND AIMS: Anesthesiologists prefer ketamine for certain surgeries due to its effectiveness as a non-competitive inhibitor of the N-methyl-D-aspartate receptor in the brain. Recently, this agent has also shown promise as an antidepressant. However, ketamine can cause hallucinogenic effects and is sometimes abused as an illicit drug. Ketamine abuse has been associated with liver and bile duct complications. This systematic study aims to better understand cholangiopathy in ketamine abusers by reviewing case reports. METHODS AND MATERIAL: In this systematic review, a comprehensive literature search was conducted with the terms "biliary tract diseases" and "ketamine". Case reports and case series of adult patients with documented ketamine abuse and reported cholangiopathy or biliary tract disease were included. We extracted the data of relevant information and the results were reported through narrative synthesis and descriptive statistics. RESULTS: A total of 48 studies were initially identified, and 11 studies were finally included in the review. The mean age of the patients was 25.88 years. Of the 17 patients, 64.7% were men. Symptoms often included abdominal pain, nausea, and vomiting. Most patients were discharged with improved symptoms and liver function. Common bile duct dilation and other findings were observed in imaging results and other diagnostic studies. CONCLUSION: This review highlights the diverse presentations and diagnostic modalities used in ketamine-induced cholangiography. These patients tend to be young men with deranged liver function tests and abdominal pain, which should be taken into consideration. These patients often require a multidisciplinary approach in their management.


Subject(s)
Biliary Tract Diseases , Biliary Tract , Illicit Drugs , Ketamine , Substance-Related Disorders , Humans , Abdominal Pain/etiology , Bile Ducts , Biliary Tract Diseases/chemically induced , Biliary Tract Diseases/complications , Ketamine/adverse effects , Substance-Related Disorders/complications , Case Reports as Topic
2.
J Acupunct Meridian Stud ; 7(3): 115-21, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24929455

ABSTRACT

There is no consensus on the management of De Quervain's tenosynovitis, but local corticosteroid injection is considered the mainstay of treatment. However, some patients are reluctant to take steroid injections. This study was performed to compare the efficacy of acupuncture versus corticosteroid injection for the treatment of this disease. Thirty patients were consequently treated in two groups. The acupuncture group received five acupuncture sessions of 30 minutes duration on classic points of LI-5, LU-7, and LU-9 and on ahshi points. The injection group received one methylprednisolone acetate injection in the first dorsal compartment of the wrist. The degree of disability and pain was evaluated by using the Quick Disabilities of the Arm, Shoulder, and Hand (Q-DASH) scale and the Visual Analogue Scale (VAS) at baseline and at 2 weeks and 6 weeks after the start of treatment. The baseline means of the Q-DASH and the VAS scores were 62.8 and 6.9, respectively. At the last follow-up, the mean Q-DASH scores were 9.8 versus 6.2 in the acupuncture and injection groups, respectively, and the mean VAS scores were 2 versus 1.2. We demonstrated short-term improvement of pain and function in both groups. Although the success rate was somewhat higher with corticosteroid injection, acupuncture can be considered as an alternative option for treatment of De Quervain's tenosynovitis.


Subject(s)
Acupuncture Points , Acupuncture Therapy , Anti-Inflammatory Agents/therapeutic use , De Quervain Disease/therapy , Methylprednisolone/analogs & derivatives , Pain/prevention & control , Adult , Anti-Inflammatory Agents/administration & dosage , De Quervain Disease/drug therapy , Female , Humans , Injections , Male , Methylprednisolone/administration & dosage , Methylprednisolone/therapeutic use , Methylprednisolone Acetate , Middle Aged , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...